정부

Meeting of the Microbiome Subcommittee of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria

Federal Register Notices
Public Domain
이 매체는 공공·자유 라이선스로 본문을 직접 표시합니다.

[Federal Register Volume 91, Number 224 (Monday, November 23, 2026)]
[Notices]
[Pages 75516-75517]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-23797]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Meeting of the Microbiome Subcommittee of the Presidential
Advisory Council on Combating Antibiotic-Resistant Bacteria

AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.

ACTION: Notice; 29th public meeting of the Presidential Advisory
Council on Combating Antibiotic-Resistant Bacteria (PACCARB).

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that a virtual meeting is scheduled to be held for the Presidential
Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB).

DATES: The meeting is scheduled to be held on December 2, 2026, at 9:00
a.m. ET (times are tentative and subject to change). The confirmed time
and agenda items for the meeting will be

[[Page 75517]]

posted on the website for the PACCARB at http://www.hhs.gov/paccarb
when this information becomes available.

ADDRESSES: The meeting will be held virtually at www.hhs.gov/live.

FOR FURTHER INFORMATION CONTACT: Sarah Mcclelland, M.P.H., Designated
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, Email: [email protected].

SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria (PACCARB), established by
Executive Order 13676, is continued by Section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are
governed by the provisions of the Federal Advisory Committee Act
(FACA), Public Law 92-463, as amended (5 U.S.C. App.), which sets forth
standards for the formation and use of federal advisory committees.
The PACCARB shall advise and provide information and
recommendations to the Secretary of Health and Human Services
(Secretary) regarding programs and policies intended to reduce or
combat antibiotic-resistant bacteria that may present a public health
threat and improve capabilities to prevent, diagnose, mitigate, or
treat such resistance. The PACCARB shall function solely for advisory
purposes.
Such advice, information, and recommendations may be related to
improving: the effectiveness of antibiotics; research and advanced
research on, and the development of, improved and innovative methods
for combating or reducing antibiotic resistance, including new
treatments, rapid point-of-care diagnostics, alternatives to
antibiotics, including alternatives to animal antibiotics, and
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health
care providers and the public with respect to up-to-date information on
antibiotic resistance and ways to reduce or combat such resistance to
antibiotics related to humans and animals; methods to prevent or reduce
the transmission of antibiotic-resistant bacterial infections;
including stewardship programs; and coordination with respect to
international efforts in order to inform and advance the United States
capabilities to combat antibiotic resistance.
The focus of the December 2, 2026, meeting will assess the current
State of the Threat that antimicrobial resistance possesses. It will
include presentations, review, and analysis of recently released data
and reports from the Centers for Disease Control (CDC), the American
Veterinary Medical Association (AVMA), the Food and Drug Administration
(FDA), and HHS. Written public comments can be emailed to [email protected]
by midnight December 30, 2026, and should be limited to no more than
one page. All public comments received prior to December 30, 2026, will
be provided to the subcommittee members.

Sarah Mcclelland,
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for
Health.
[FR Doc. 2026-23797 Filed 11-20-26; 8:45 am]
BILLING CODE 4150-44-P

공식 발표 ↔ 매체 보도

진보 성향0

보도 없음

중도 성향0

보도 없음

보수 성향0

보도 없음